{"result": "(\"entity\"<|>ETILENO ACETATO DE VINILO<|>ORGANIZATION<|>Etileno acetato de vinilo (EVA) is a material used for plastic bags that hold parenteral nutrition solutions, designed to reduce oxidation.)\n##\n(\"entity\"<|>PVC<|>ORGANIZATION<|>PVC (cloruro de polivinilo) is a material used in infusion systems for parenteral nutrition, which should not contain di (2-etilhexil) ftalato (DEHP).)\n##\n(\"entity\"<|>FILTRACIÓN<|>EVENT<|>Filtration is a process used in parenteral nutrition systems to prevent air entry and retain particles and bacteria.)\n##\n(\"entity\"<|>SOLUCIONES BINARIAS<|>ORGANIZATION<|>Binary solutions consist of amino acids and glucose on one side and lipids on the other, used in parenteral nutrition.)\n##\n(\"entity\"<|>ADMINISTRACIÓN CÍCLICA<|>EVENT<|>Cyclical administration is a method of delivering parenteral nutrition that allows for breaks from intravenous fluid therapy, facilitating patient activity.)\n##\n(\"entity\"<|>MEZCLAS TERNARIAS<|>ORGANIZATION<|>Ternary mixtures combine amino acids, glucose, and lipids for parenteral nutrition, preferred for pediatric patients.)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>ETILENO ACETATO DE VINILO<|>Etileno acetato de vinilo is used in bags for parenteral nutrition solutions to minimize oxidation<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>PVC<|>PVC is used in the construction of infusion systems for parenteral nutrition<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>FILTRACIÓN<|>Filtration is a critical process in the administration of parenteral nutrition to ensure safety<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>SOLUCIONES BINARIAS<|>Binary solutions are still used in pediatric parenteral nutrition despite the trend towards ternary solutions<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>ADMINISTRACIÓN CÍCLICA<|>Cyclical administration is a method applied in pediatric parenteral nutrition to improve patient outcomes<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>MEZCLAS TERNARIAS<|>Ternary mixtures are increasingly utilized in pediatric parenteral nutrition for better nutrient delivery<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: vitamina A = 3,3 UI; 1 μg de vitamina D = 10 UI. ¹RNPT (recién nacido pretérmino) con enfermedad pulmonar: 1500-2800 UI. Dosis Infuvite Pediátrico®: RNPT < 1 kg peso 1,5 ml; 1-3 kg peso 3 ml; resto edades: 5 ml.\n\nmicas recomendadas para cada rango de edad son las siguientes:\n\n- Lactantes pequeños: 0,5 cm por encima de la carina.\n- Lactantes mayores: 1 cm por encima de la carina.\n- Niño mayor: a la altura de la carina.\n\nSi el abordaje se realiza por la vena femoral la punta del catéter deberá quedar por encima del diafragma y en ningún caso a la altura de las venas renales.\n\nPor lo general, los CVC percutáneos se usan en situaciones agudas, para administración de NP de corta duración (<15 días). Una buena opción para situaciones en las que se prevea una NP de duración intermedia, de hasta 3-6 meses, son los CVC de abordaje periférico, tipo PICC (Peripherally Inserted Central catheter, catéter venoso central de abordaje periférico) con una tasa de complicaciones más baja que los CVC percutáneos⁵⁰. Por último, en caso de que se prevea que la NP va a ser prolongada, lo ideal es disponer de un catéter permanente, siendo los catéteres tunelizados los de elección. Si es posible, es preferible utilizar catéteres de una sola luz y, en aquellos casos en los que se opte por un catéter de varias luces, utilizar siempre la misma luz para la NP de forma exclusiva.\n\n## 7. Material para la administración de nutrición parenteral\n\nLa infusión de la NP se realizará siempre mediante bombas de infusión. Las soluciones se recogen en bolsas plásticas, sobre todo de etileno acetato de vinilo (EVA) o en bolsas multicapa, que combinan una capa de EVA con otras de distinto material para disminuir el paso de oxígeno y, por tanto, disminuir las posibilidades de oxidación. Las bolsas generalmente van recubiertas de un material que las protege de la luz con el fin de evitar los fenómenos de degradación y peroxidación por la sobreexposición de los lípidos y vitaminas a la luz⁵¹. Los sistemas de infusión o nutrilíneas utilizan PVC (cloruro de polivinilo) como material, y no deberían contener di (2-etilhexil) ftalato (DEHP)⁵². Se recomienda el uso de sistemas opacos en vez de los transparentes habituales para evitar la peroxidación lipídica, así como la utilización de filtros que previenen la entrada de aire en el sistema venoso al tiempo que retienen partículas y bacterias⁵³. Se utilizarán filtros de 0,22 μm para las soluciones sin lípidos y de 1,2 para las mezclas ternarias⁵⁴.\n\n## 8. Métodos de infusión\n\nAunque se continúan utilizándose soluciones binarias (AA + glucosa por una parte y lípidos por otra), la\n---\nBLOQUE: NUTRICIÓN PEDIÁTRICA\n\ntendencia es a utilizar soluciones ternarias siempre que sea posible. Por el riesgo que supone la mezcla de heparina, lípidos y calcio en la misma solución, no se utiliza heparina de forma rutinaria en nuestras soluciones de NP. En la mayoría de las ocasiones las soluciones individualizadas continúan siendo la norma en pediatría, pues permiten un ajuste fino de los aportes55. Sin embargo, en pacientes mayores o en lugares donde no haya un farmacéutico disponible puede ser útil tener soluciones estandarizadas para niños56.\n\nHabitualmente, la NP en niños se administra de forma continua a lo largo de 24 horas. Este método es aplicable tanto cuando se usan mezclas ternarias como cuando los lípidos se administran separadamente. En determinadas situaciones puede ser interesante la administración cíclica de la NP. Esta forma de infusión facilita la movilización de grasas produciendo menor infiltración grasa hepática y menor déficit de ácidos grasos esenciales57. Además, permite al paciente verse libre de fluidoterapia endovenosa durante un periodo de tiempo (6 a 12 horas), facilitando su actividad. En la práctica clínica utilizamos este método de infusión en el paciente con NP de larga duración y/o domiciliaria, así como en aquellos con afectación hepática importante asociada al uso de NP.\n\nMuchos de los pacientes que reciben NP reciben además otras medicaciones intravenosas; esto plantea con frecuencia preguntas acerca de la estabilidad de estos fármacos con las soluciones de NP, sobre todo en aquellas situaciones en que no se dispone de múltiples vías o de\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>NUTRICIÓN PEDIÁTRICA<|>EVENT<|>NUTRICIÓN PEDIÁTRICA refers to the specialized nutritional care provided to infants and children, particularly those who require parenteral nutrition due to medical conditions or surgeries.)\n##\n(\"entity\"<|>CVC PERCUTÁNEOS<|>ORGANIZATION<|>CVC percutáneos are central venous catheters used in acute situations for short-term parenteral nutrition administration.)\n##\n(\"entity\"<|>CVC DE ABORDAJE PERIFÉRICO<|>ORGANIZATION<|>CVC de abordaje periférico, such as PICC, are used for intermediate-term parenteral nutrition, offering lower complication rates than percutaneous CVCs.)\n##\n(\"entity\"<|>CATÉTER PERMANENTE<|>ORGANIZATION<|>Permanent catheters are ideal for prolonged parenteral nutrition, with tunneled catheters being the preferred choice.)\n##\n(\"entity\"<|>BOMBAS DE INFUSIÓN<|>ORGANIZATION<|>Infusion pumps are used to administer parenteral nutrition solutions continuously over 24 hours.)\n##\n(\"entity\"<|>SOLUCIONES TERNARIAS<|>ORGANIZATION<|>Ternary solutions are preferred for parenteral nutrition in pediatrics, combining amino acids, glucose, and lipids.)\n##\n(\"entity\"<|>HEPARINA<|>ORGANIZATION<|>Heparin is not routinely used in parenteral nutrition solutions due to the risks associated with mixing it with lipids and calcium.)\n##\n(\"entity\"<|>PACIENTES<|>PERSON<|>Patients receiving parenteral nutrition, particularly children, who may also require other intravenous medications.)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>CVC PERCUTÁNEOS<|>CVC percutáneos are used in pediatric nutrition for short-term intravenous access<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>CVC DE ABORDAJE PERIFÉRICO<|>CVC de abordaje periférico are utilized for intermediate-term parenteral nutrition in pediatric patients<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>CATÉTER PERMANENTE<|>Permanent catheters are recommended for prolonged parenteral nutrition in pediatric care<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>BOMBAS DE INFUSIÓN<|>Infusion pumps are essential for administering parenteral nutrition continuously in pediatric patients<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>SOLUCIONES TERNARIAS<|>Ternary solutions are increasingly used in pediatric parenteral nutrition for better nutrient management<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>HEPARINA<|>Heparin is avoided in pediatric parenteral nutrition solutions due to safety concerns<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN PEDIÁTRICA<|>PACIENTES<|>Patients receiving parenteral nutrition often require careful management of their nutritional needs<|>9)\n<|COMPLETE|>"}]}